Clinical Trials
291 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
Clinical Genetics Branch Eligibility Screening Survey
National Institutes of Health Clinical Center (CC)
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
National Institutes of Health Clinical Center (CC)
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
St. Jude Children's Research Hospital
Tumor HI
Rezolute
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
M.D. Anderson Cancer Center
SaLuDo
PharmaMar
A Study of DEG6498 in Participants With Solid Tumors
Degron Therapeutics Co.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
I-SPY
QuantumLeap Healthcare Collaborative
SPiReL
Sunnybrook Health Sciences Centre
Project: Every Child for Younger Patients With Cancer
Children's Oncology Group
POLMS
Azienda USL Reggio Emilia - IRCCS
Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
Lantern Pharma Inc.
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
National Institutes of Health Clinical Center (CC)
Indocyanine Green (ICG) Guided Tumor Resection
St. Jude Children's Research Hospital
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
NAVIGATE
Bayer
ATEZOGIST
Centre Leon Berard
T-LyM
University of Rochester
PROTONBIOMARKS
Centre Leon Berard
CONGRATS
Institut Bergonié
ISOMUTAR
University Hospital, Lille
IGNYTE-ESO
USWM, LLC (dba US WorldMeds)
SARCOPALL
Centre Leon Berard
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Information-providing Chatbot
The Hong Kong Polytechnic University
LiFFT
Children's Hospital of Philadelphia
FLAGSHP-1
Erasca, Inc.
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
AIDS Malignancy Consortium
PALANGI3
Centre Oscar Lambret
FURTHER
UMC Utrecht
AflacST1502
Emory University
IDOV-Immune for Advanced Solid Tumors
ViroMissile, Inc.
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
SEED Therapeutics, Inc.
EBNK-ST-001
Essen Biotech
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Angiex, Inc.
LIGHT-CTC
Centre Leon Berard
Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer
St. Jude Children's Research Hospital
AYA STEPS
Duke University
BRICCS
Mayo Clinic
Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)
GlaxoSmithKline
Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)
M.D. Anderson Cancer Center
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
LIBRETTO-121
Eli Lilly and Company
VARTUTRACE
Var2 Pharmaceuticals
PROSa+
Technische Universität Dresden
Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor
Rezolute
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Memorial Sloan Kettering Cancer Center